Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Brief Description Of Study

The purpose of this trial is to determine the efficacy and provide further safety data on glycemic control in stroke patients. The study population of approximately 1400 patients will include hyperglycemic acute ischemic stroke patients of either gender who are 18 years of age or older. They will have a history of type 2 diabetes and hyperglycemia or in the absence of diabetes, must have a baseline glucose levels greater than or equal to 150 g/dL. To be eligible treatment must begin within 3 hours of arrival to the Emergency department and within 12 hours of stroke symptom onset. Participation is limited to those with baseline NIHSS scores 3-22. Patients that meet all eligibility criteria will receive up to 72 hours of hyperglycemia control with IV insulin therapy or control therapy with subcutaneous insulin. Treatment will be given within 12 hours of symptom onset and is recommended, but not required, to begin within 3 hours of arrival to the emergency department.

Clinical Study Identifier: 814792

Contact research investigator to learn more about this study by filling out the form below.

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.